NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
FG Group Holdings Inc. (NYSE: FGH)’s sale to FG Financial Group, Inc. for one share of FG Financial common stock for each share of FG Group common stock. Upon closing of the proposed transaction, FG Group shareholders will own 72% of the outstanding shares of the combined company. If you are an FG Group shareholder, click here to learn more about your rights and options.
Axonics, Inc. (NASDAQ: AXNX)’s sale to Boston Scientific Corporation for $71.00 in cash per share. If you are an Axonics shareholder, click here to learn more about your rights and options.
Ambrx Biopharma, Inc. (NASDAQ: AMAM)’s sale to Johnson & Johnson for $28.00 per share in cash. If you are an Ambrx shareholder, click here to learn more about your rights and options.
Harpoon Therapeutics, Inc. (NASDAQ: HARP)’s sale to Merck for $23.00 per share in cash. If you are a Harpoon shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
